Integral Ad Science Holding Corp. (NASDAQ:IAS) Shares Acquired by Bank of New York Mellon Corp

Key Points

• Bank of New York Mellon Corp increased its stake in Integral Ad Science Holding Corp. by 15.9%, acquiring an additional 39,988 shares, bringing its total holdings to 291,079 shares valued at approximately $2.35 million.
• Institutional investors own 95.78% of Integral Ad Science shares, with recent acquisitions by firms like Vanguard Group and UBS AM further boosting their positions.
• Analysts have a consensus rating of "Moderate Buy" for Integral Ad Science, with an average price target of $13.65, as various firms adjust their price objectives and ratings.

Bank of New York Mellon Corp increased its holdings in Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 15.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 291,079 shares of the company's stock after purchasing an additional 39,988 shares during the quarter. Bank of New York Mellon Corp owned approximately 0.18% of Integral Ad Science worth $2,346,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of IAS. Raymond James Financial Inc. purchased a new position in shares of Integral Ad Science during the fourth quarter valued at approximately $807,000. KLP Kapitalforvaltning AS purchased a new position in Integral Ad Science in the 4th quarter worth approximately $257,000. Vanguard Group Inc. raised its holdings in Integral Ad Science by 2.3% in the 4th quarter. Vanguard Group Inc. now owns 9,048,546 shares of the company's stock worth $94,467,000 after acquiring an additional 205,562 shares during the last quarter. Geode Capital Management LLC raised its holdings in Integral Ad Science by 0.8% in the 4th quarter. Geode Capital Management LLC now owns 1,848,738 shares of the company's stock worth $19,305,000 after acquiring an additional 14,079 shares during the last quarter. Finally, Wells Fargo & Company MN raised its stake in Integral Ad Science by 9.8% during the 4th quarter. Wells Fargo & Company MN now owns 85,089 shares of the company's stock valued at $888,000 after buying an additional 7,587 shares during the last quarter. 95.78% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on IAS. Wall Street Zen raised shares of Integral Ad Science from a "hold" rating to a "buy" rating in a research report on Saturday, June 14th. Morgan Stanley cut their price objective on shares of Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating for the company in a research report on Thursday, April 17th. Stifel Nicolaus boosted their price objective on shares of Integral Ad Science from $13.00 to $14.00 and gave the company a "buy" rating in a research report on Tuesday, July 22nd. Raymond James Financial boosted their price objective on shares of Integral Ad Science from $11.00 to $13.00 and gave the company an "outperform" rating in a research report on Tuesday, May 13th. Finally, Barclays upped their target price on shares of Integral Ad Science from $7.00 to $9.00 and gave the stock an "equal weight" rating in a report on Tuesday, May 13th. Six equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, Integral Ad Science presently has a consensus rating of "Moderate Buy" and a consensus target price of $13.65.

Insiders Place Their Bets

In other Integral Ad Science news, CEO Lisa Utzschneider sold 8,285 shares of the firm's stock in a transaction that occurred on Thursday, July 10th. The shares were sold at an average price of $8.29, for a total value of $68,682.65. Following the completion of the sale, the chief executive officer directly owned 371,031 shares in the company, valued at $3,075,846.99. This trade represents a 2.18% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders have sold 33,518 shares of company stock valued at $270,739 in the last three months. 2.00% of the stock is owned by company insiders.

Integral Ad Science Price Performance

Shares of NASDAQ IAS traded down $0.33 during mid-day trading on Friday, hitting $7.88. 429,008 shares of the company's stock traded hands, compared to its average volume of 1,025,657. The company has a debt-to-equity ratio of 0.01, a current ratio of 4.01 and a quick ratio of 4.01. Integral Ad Science Holding Corp. has a 1 year low of $6.26 and a 1 year high of $13.62. The company has a market capitalization of $1.30 billion, a P/E ratio of 27.16, a PEG ratio of 1.39 and a beta of 1.57. The company's 50-day moving average is $8.18 and its two-hundred day moving average is $8.61.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last released its quarterly earnings data on Monday, May 12th. The company reported $0.05 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.03 by $0.02. Integral Ad Science had a net margin of 8.56% and a return on equity of 4.74%. The firm had revenue of $134.07 million for the quarter, compared to the consensus estimate of $129.20 million. On average, equities analysts anticipate that Integral Ad Science Holding Corp. will post 0.26 EPS for the current fiscal year.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.